SCHEMBL29285290

SCHEMBL29285290

OC1=C(OCc2ccccc2)CCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
CYP1A2 P05177 1/20 0.48
PTGS1 P23219 1/20 0.48
SLC6A2 P23975 1/20 0.48
CYP2C19 P33261 1/20 0.48
PTGS2 P35354 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HIF1A Q16665 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HPD P32754 1/20 0.41
MAOB P27338 5/20 0.41
MAOA P21397 4/20 0.41
DHODH Q02127 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19914172 0.89 LMNA (0.52) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL11154487 0.74 L3MBTL1 (0.47) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL3660167 0.74 TSHR (0.48) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL11227711 0.73 MAOB (0.39) LMNACYP1A2PTGS1SLC6A2CYP2C19
Bromide SCHEMBL11142191 0.71 MAOB (0.37) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL3278335 0.70 TSHR (0.48) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL11233344 0.69 MAOB (0.39) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL6469379 0.69 TSHR (0.52) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL1061320 0.68 TSHR (0.46) LMNACYP1A2PTGS1SLC6A2CYP2C19
Monobenzone SCHEMBL8450838 0.66 LMNA (1.00) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850280-B Preparation method of antiviral drug entecavir intermediate N4 南京康立瑞生物科技有限公司 2024-07-05 CN disclosed
CN-115850280-A Preparation method of antiviral drug entecavir intermediate N4 南京康立瑞生物科技有限公司 2023-03-28 CN disclosed